Brazil’s Pharma Market

Brazil: valued at approximately USD 19.7 billion in 2023, with projections to grow to USD 42.90 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 10.20%​ (Market Research Future)​​ (Fitch Solutions)​.

Brazil’s biopharmaceutical market has experienced dramatic changes since 2000, with improvements in the performance of local firms, as well as an expansion in consumer demand and productive capacity, which have made the country the sixth largest market in the world. (https://ipc.mit.edu)

The Brazilian drug market has traded BRL 106,78 billion in 2022, equivalent to USD 20.70 billion [Canal Farmácia (Pharmacy Channel), net value – average discount of 37.58 %], according to surveys by consultancy company IQVIA. There was an increase of 16,95 % in BRL, compared to the previous year, representing approximately 2 % of the world market, being the 10th in revenue in the ranking of the 20 main economies. In Latin America, it is the main market, ahead of Mexico, Colombia and Argentina. (Sindusfarma)